We use essential cookies and third-party cookies for content.

Arizona Tribune - Tenon Medical, Inc. Sets Date for Second Quarter 2026 Earnings

Arizona Tribune
×
NYSE - LSE
CMSC -1.38% 20.33 $
GSK -1.9% 49.775 $
BTI -0.04% 55.73 $
BCC -0.99% 78.225 $
AZN -2.9% 163.62 $
CMSD -1.04% 20.21 $
NGG -2% 75.35 $
RBGPF -3.92% 64.47 $
RIO -2.5% 95.11 $
RYCEF 0.6% 20 $
BCE -0.51% 21.59 $
BP 3.07% 44.465 $
JRI -2.27% 11.23 $
RELX 0.9% 33.28 $
VOD -1.56% 16.365 $
Tenon Medical, Inc. Sets Date for Second Quarter 2026 Earnings
Tenon Medical, Inc. Sets Date for Second Quarter 2026 Earnings

Tenon Medical, Inc. Sets Date for Second Quarter 2026 Earnings

BOULEVARD 30.07.2026

LOS GATOS, CA / ACCESS Newswire / July 30, 2026 / Tenon Medical, Inc. (NASDAQ:TNON)("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today announced plans to release financial results for the second quarter ended June 30, 2026 after market close on Thursday, August 13, 2026. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.

Text size:

Date:

Thursday, August 13, 2026

Time:

4:30 p.m. Eastern time

Dial-in:

1-877-407-0792

International Dial-in:

1-201-689-8263

Webcast:

TNON Conference Call

Please dial in at least 10 minutes before the start of the call to ensure timely participation.

An audio playback of the call will be available through August 27, 2026,on Tenon's Investor Relations website at http://ir.tenonmed.com/ or via telephone replay by dialing 1-844-512-2921 (USA) or 1-412-317-6671(International). The access code will be 13761819.

About Tenon Medical, Inc.

Tenon Medical, Inc. is a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders. Tenon was incorporated in the State of Delaware in 2012 and currently offers two systems to treat a diseased sacroiliac joint (the "SI Joint"). The Company has developed The Catamaran™ SI Joint Fusion System that offers a novel, less invasive approach to the SI Joint using a single, robust titanium implant. In August 2025, the Company acquired substantially allof the assets of SiVantage, Inc. and SIMPL Medical, LLC, including the SImmetry+® SI Joint Fusion System, which treats disorders of the SI Joint through a minimally invasive lateral access solution that incorporates well-established orthopedic fusion principles. Since the national launch of The Catamaran System in October 2022, Tenon is focused on three commercial opportunities: 1) primary SI Joint procedures, 2) revision procedures of failed SI Joint implants and 3) SI-Joint fusion adjunct to a spine fusion construct.

For more information, please visit www.tenonmed.com. Information on the Company's website does not constitute a part of and is not incorporated by reference into this press release.

The Tenon Medical logo shown above, and Catamaran®, PiSIF®, CAT PiSIF®, ETAD®, Posterior Inferior Sacroiliac Fusion®, CAT SIJ Fusion System®, Catamaran SIJ Fusion System®, Catamaran Inferior Posterior Fusion System®, Catamaran Transfixation Fusion System®, Catamaran Transfixation Fusion Device®, SImmetry® are registered trademarks of Tenon Medical, Inc. MAINSAILTM, and SImmetry+ are also trademarks of Tenon Medical, Inc.

IR Contact:
Shannon Devine
203-741-8811
MZ North America
[email protected]

SOURCE: Tenon Medical, Inc.



View the original press release on ACCESS Newswire

O.Ortiz--AT

Featured

Grief and pain flow at hearing for Canadian suicide poison vendor

Grief and pain flow at hearing for Canadian suicide poison vendor
Weinstein resentenced to 15 years in prison for 2006 sex assault

Weinstein resentenced to 15 years in prison for 2006 sex assault
French court confirms rape trial for PSG and Morocco star Hakimi

French court confirms rape trial for PSG and Morocco star Hakimi
Turkey reassures investors over investment fund crisis

Turkey reassures investors over investment fund crisis